Evidence map›Paper›PMID 39039782›Full record

ArticleInternational journal of cancer2025

Asparagine synthetase and G-protein coupled estrogen receptor are critical responders to nutrient supply in KRAS mutant colorectal cancer.

Lingeng Lu, Qian Zhang, Oladimeji Aladelokun, Domenica Berardi, Xinyi Shen, Audrey Marin, Rolando Garcia-Milian, Jatin Roper, Sajid A Khan, Caroline H Johnson

Abstract read
In one paragraph

Article in International journal of cancer, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Observational
  6. 17β-estradiol in colorectal cancer: friend or foe?Cell communication and signaling : CCS · 2024
    Review
  7. Article
  8. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors.

Lingeng LuDepartment of Chronic Disease Epidemiology, Yale School of Public Health, Yale University, New Haven, Connecticut, USA.ORCID 0000-0001-9871-0809
Qian ZhangDepartment of Environmental Health Sciences, Yale School of Public Health, Yale University, New Haven, Connecticut, USA.
Oladimeji AladelokunDepartment of Environmental Health Sciences, Yale School of Public Health, Yale University, New Haven, Connecticut, USA.
Domenica BerardiDepartment of Environmental Health Sciences, Yale School of Public Health, Yale University, New Haven, Connecticut, USA.
Xinyi ShenDepartment of Environmental Health Sciences, Yale School of Public Health, Yale University, New Haven, Connecticut, USA.
Audrey MarinDepartment of Environmental Health Sciences, Yale School of Public Health, Yale University, New Haven, Connecticut, USA.
Rolando Garcia-MilianDepartment of Environmental Health Sciences, Yale School of Public Health, Yale University, New Haven, Connecticut, USA.
Jatin RoperDivision of Gastroenterology, Department of Medicine, Duke University, Durham, North Carolina, USA.
Sajid A KhanSection of Surgical Oncology, Department of Surgery, Yale School of Medicine, Yale Cancer Center, Yale University, New Haven, Connecticut, USA.
Caroline H JohnsonDepartment of Environmental Health Sciences, Yale School of Public Health, Yale University, New Haven, Connecticut, USA.

Funding

Yale Clinical and Translational Science Award (U Component)UL1TR001863 · NCATS · YALE UNIVERSITY · PI John H. Krystal, LUCILA OHNO-MACHADO · 2016 to 2026
$102.9M
The Yale Cancer Prevention and Control Training ProgramT32CA250803 · NCI · YALE UNIVERSITY · PI Melinda L Irwin, Xiaomei Ma · 2020 to 2026
$2.3M
Wnt signaling in obesity-associated colorectal cancerR37CA259363 · NCI · DUKE UNIVERSITY · PI Jatin Roper · 2022 to 2026
$1.8M
Role and Regulation of Asparagine in Colorectal CancerR01CA289440 · NCI · YALE UNIVERSITY · PI Caroline Helen Johnson, Sajid A Khan · 2025 to 2026
$1.4M
High Performance Computing Instrumentation for the Yale Center for Genome AnalysisS10OD030363 · OD · YALE UNIVERSITY · PI MANE, SHRIKANT M · 2022 to 2022
$1.2M
American Cancer Society 134273-RSG-20-065-01-TBENCATS NIH HHS UL1 TR001863NCI NIH HHS R01 CA289440NCI NIH HHS R37 CA259363NCI NIH HHS T32 CA250803NIH HHS 1S10OD030363-01A1 (YCGA)NIH HHS NCI R37CA259363NIH HHS S10 OD030363
6 · The paper itself

Abstract

Survival differences exist in colorectal cancer (CRC) patients by sex and disease stage. However, the potential molecular mechanism(s) are not well understood. Here we show that asparagine synthetase (ASNS) and G protein-coupled estrogen receptor-1 (GPER1) are critical sensors of nutrient depletion and linked to poorer outcomes for females with CRC. Using a 3D spheroid model of isogenic SW48 KRAS wild-type (WT) and G12A mutant (MT) cells grown under a restricted nutrient supply, we found that glutamine depletion inhibited cell growth in both cell lines, whereas ASNS and GPER1 expression were upregulated in KRAS MT versus WT. Estradiol decreased growth in KRAS WT but had no effect on MT cells. Selective GPER1 and ASNS inhibitors suppressed cell proliferation with increased caspase-3 activity of MT cells under glutamine depletion condition particularly in the presence of estradiol. In a clinical colon cancer cohort from The Cancer Genome Atlas, both high GPER1 and ASNS expression were associated with poorer overall survival for females only in advanced stage tumors. These results suggest KRAS MT cells have mechanisms in place that respond to decreased nutrient supply, typically observed in advanced tumors, by increasing the expression of ASNS and GPER1 to drive cell growth. Furthermore, KRAS MT cells are resistant to the protective effects of estradiol under nutrient deplete conditions. The findings indicate that GPER1 and ASNS expression, along with the interaction between nutrient supply and KRAS mutations shed additional light on the mechanisms underlying sex differences in metabolism and growth in CRC, and have clinical implications in the precision management of KRAS mutant CRC.

Indexed as

Aspartate-Ammonia LigaseCell ProliferationColorectal NeoplasmsMutationProto-Oncogene Proteins p21(ras)Receptors, EstrogenReceptors, G-Protein-CoupledCarbon-Nitrogen Ligases with Glutamine as Amide-N-DonorCell Line, TumorEstradiolFemaleGene Expression Regulation, NeoplasticGlutamineHumansMaleNutrientsASNS protein, humanAspartate-Ammonia LigaseCarbon-Nitrogen Ligases with Glutamine as Amide-N-DonorEstradiolGlutamineGPER1 protein, humanKRAS protein, humanNutrientsProto-Oncogene Proteins p21(ras)Receptors, EstrogenReceptors, G-Protein-CoupledASNScolorectal cancerestradiolglutamineGPER1survival

Identifiers

PMID39039782
PMCPMC11537827

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.